(Q84790645)

English

A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA

scientific article published on August 21, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Valerian Pinto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ping Chen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Paul B. Keiser

1

0000-0002-6271-4426

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

Barnett T. Gibbs

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

Trinka S. Coster

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

E. Ellen Moran

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

Mark B. Stoddard

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

Joseph E. Labrie

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

Deborah H. Schmiel

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

Wendell D. Zollinger

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732470

21 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20732470

21 June 2024

publication date

21 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X1001193X?httpAccept=text/xml

1 reference

10.1016/J.VACCINE.2010.08.048

https://api.crossref.org/works/10.1016/J.VACCINE.2010.08.048

21 June 2024

https://api.elsevier.com/content/article/PII:S0264410X1001193X?httpAccept=text/plain

1 reference

10.1016/J.VACCINE.2010.08.048

https://api.crossref.org/works/10.1016/J.VACCINE.2010.08.048

21 June 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

6970-6976

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine

23

1 reference

10.1016/J.VACCINE.2010.08.048

https://api.crossref.org/works/10.1016/J.VACCINE.2010.08.048

21 June 2024

Identifiers

10.1016/J.VACCINE.2010.08.048

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84790645&oldid=2185430598"